Bakker Juliet Tammenoms's Net Worth
$533 Million
Who is Bakker Juliet Tammenoms?
Bakker Juliet Tammenoms has an estimated net worth of $533 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, Esperion Therapeutics, Inc., Inozyme Pharma, Inc., Lexeo Therapeutics, Inc., Axonics Modulation Technologies, Inc., Vera Therapeutics, Inc., RAPID MICRO BIOSYSTEMS, INC., RxSight, Inc., Tricida, Inc., Talaris Therapeutics, Inc., Sierra Oncology, Inc., Vaxcyte, Inc., 89bio, Inc., Eargo, Inc., Kala Pharmaceuticals, Inc., Venus Concept Inc., Molecular Templates, Inc., Aptinyx Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Bakker Juliet Tammenoms's CIK is 0001431159
Past Insider Trading and Trends
2021 was Bakker Juliet Tammenoms's most active year for acquiring shares with 18 total transactions. Bakker Juliet Tammenoms's most active month to acquire stocks was the month of October. 2014 was Bakker Juliet Tammenoms's most active year for disposing of shares, totalling 26 transactions. Bakker Juliet Tammenoms's most active month to dispose stocks was the month of October. 2023 saw Bakker Juliet Tammenoms paying a total of $22,999,990.00 for 4,838,358 shares, this is the most they've acquired in one year. In 2022 Bakker Juliet Tammenoms cashed out on 3,616,896 shares for a total of $19,498,050.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $5.385
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +48.06% | 1.35M |
$3.69 | $4,999,950.00 | 4.17M |
Apr 19
| |||
Form 4
|
∞
| 2.82M |
$16.00 |
—
| 2.82M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.57M |
$11.00 |
—
| 2.57M |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RAPID MICRO BIOSYSTEMS, INC. (RPID) Snapshot price: $0.935
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,466.78% | 3.49M |
$20.00 | $3,000,000.00 | 3.56M |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.10% | -1.00M |
$17.34 | -$17,340,000.00 | 2.32M |
Dec 8
| |||
Form 4
|
∞
| 3.32M |
$12.00 |
—
| 3.32M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tricida, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.56% | 3.02M |
$19.00 | $2,500,001.00 | 5.91M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |